Abstract The complex pathogenesis of temporal lobe epilepsy includes neuronal and glial pathology, synaptic reorganization, and an immune response. However, the spatio-temporal pattern of structural changes in the brain that provide a substrate for seizure generation and modulate the seizure phenotype is yet to be completely elucidated. We used quantitative magnetic resonance imaging (MRI) to study structural changes triggered by status epilepticus (SE) and their association with epileptogenesis and with activation of complement component 3 (C3). SE was induced by injection of pilocarpine in CD1 mice. Quantitative diffusion-weighted imaging and T2 relaxometry was performed using a 16.4-Tesla MRI scanner at 3 h and 1, 2, 7, 14, 28, 35, and 49 days post-SE. Following longitudinal MRI examinations, spontaneous recurrent seizures and interictal spikes were quantified using continuous video-EEG monitoring. Immunohistochemical analysis of C3 expression was performed at 48 h, 7 days, and 4 months post-SE. MRI changes were dynamic, reflecting different outcomes in relation to the development of epilepsy. Apparent diffusion coefficient changes in the hippocampus at 7 days post-SE correlated with the severity of the evolving epilepsy. C3 activation was found in all stages of epileptogenesis within the areas with significant MRI changes and correlated with the severity of epileptic condition.
Introduction
Temporal lobe epilepsy (TLE), the most common form of refractory focal epilepsy in adults, is associated with widespread structural changes in neuronal networks of the hippocampus and medial temporal lobe (Engel et al. 2008; Bonilha et al. 2012) . Mesial temporal sclerosis with neuronal loss and gliosis in the hippocampus is the most common pathology associated with TLE and can often be detected on visual inspection of clinical magnetic resonance imaging (MRI) scans. However, more detailed morphometric studies have consistently demonstrated changes in extra-hippocampal and extra-temporal limbic structures in patients with refractory TLE (Keller et al. 2002; Bonilha et al. 2003; Bernasconi et al. 2004; McDonald et al. 2008) .
In most affected patients, TLE is thought to be initiated by insults such as febrile convulsions, status epilepticus, encephalitis, or traumatic brain injury (French et al. 1993; Mathern et al. 1995; VanLandingham et al. 1998) , following which patients enter a latent period. During this latent period, structural and physiological changes in the brain render it capable of generating recurrent spontaneous seizures, a process referred to as epileptogenesis (Pitkanen 2010) . Structural changes that contribute to epileptogenesis are the focus of active investigation and are thought to include neurodegeneration, neurogenesis, gliosis, axonal damage and/or sprouting, dendritic plasticity, changes in the extracellular matrix and angiogenesis (Herman 2006; Pitkanen and Lukasiuk 2011) . Emerging evidence from both experimental and clinical gene expression studies strongly indicates activation of innate immunity and particularly of the complement system in association with TLE (Jamali et al. 2006 (Jamali et al. , 2010 Aronica et al. 2007; van Gassen et al. 2008) . It has been hypothesized that activation of the complement cascade contributes to the development and perpetuation of increased seizure susceptibility in the epileptic focus.
Epileptogenesis is a dynamic process and its relationship with evolving structural changes in different brain regions after the initial injury is not well understood. A better understanding of this relationship is needed to develop novel targeted therapies but prospective population-based studies in humans are scarce and limited by small patient cohorts and short follow-up periods. Animal models that mimic the behavioral and neurophysiological features of human TLE provide an excellent alternative to study the process of epileptogenesis. Chronic epilepsy models, particularly models based on an inciting event of limbic status epilepticus (SE) have been long regarded as highly isomorphic with the human disease since they reproduce most of the key clinical and neuropathological characteristics of TLE. An initial insult (SE) is followed by a latent period of variable duration that culminates in the development of spontaneous recurrent seizures (SRS). Histological changes such as neuronal death, neurogenesis, synaptic reorganization, reactive gliosis, and inflammation are observed in a number of cortical and subcortical brain regions and continue long after the termination of the initial insult (White 2002; Buckmaster 2004; Sharma et al. 2007) .
In this study, we examined the time course and pattern of structural changes and complement C3 activation following the precipitating injury in an experimental model of TLE in mice. We studied the relationship between these changes and epileptogenesis by evaluating their correlation with electrophysiological characteristics of the epileptic syndrome. Administration of the chemoconvulsant muscarinic agonist pilocarpine induced SE followed by SRS in mice (Cavalheiro et al. 1996; Shibley and Smith 2002) . As in the clinical scenario in which not all individuals that incur an initial insult develop spontaneous seizures, in this model at lower doses of pilocarpine, only 30-40 % of animals become epileptic (Cavalheiro et al. 1996; Shibley and Smith 2002; Borges et al. 2003; Curia et al. 2008) . This feature of the model permitted us to compare subjects with different outcomes (epilepsy vs. no epilepsy) following the same type of brain injury.
We used high-resolution quantitative diffusion-weighted imaging (DWI) and T2 relaxation measurements to assess structural alterations at different time-points after pilocarpine administration. These parameters were chosen because previous studies showed that T2 relaxometry detects hippocampal sclerosis with high sensitivity in TLE patients (Jackson et al. 1993; Kuzniecky et al. 1997; Briellmann et al. 2002; Pell et al. 2004 ) and that DWI is a sensitive marker of acute brain injury in both humans and experimental TLE models (Nakasu et al. 1995; Wang et al. 1996; Wall et al. 2000; Fabene et al. 2006) . Radiologically, hippocampal sclerosis is indicated by the combination of increased hippocampal T2-weighted signal and decreased hippocampal volume (Jackson et al. 1990 ), so we performed MRI-based volumetric analysis of the hippocampus. We also studied the expression of complement C3, the key molecule in the complement system that ultimately drives its effector functions, during the acute, sub-acute and chronic post-injury phases. The relationship between imaging, histological findings and electrophysiological changes was evaluated.
Materials and methods

Animals
The present study was approved by The University of Queensland's Institutional Animal Ethics Committee (UQ AEC Certificate CAI/359/10/NHMRC). Seventy-seven male, outbred CD1 mice weighing 34 ± 3.2 g and aged 7-8 weeks were included in this study. Animals were kept under controlled laboratory conditions (12 h light/12 h dark cycle with lights on at 07:00 a.m., temperature 22 ± 1°C, air humidity 50-60 %), and had ad libitum access to food and water. The mice were housed individually and given 72 h to acclimate before the experiment.
Induction of epilepsy
The procedure for creating the model has been described in detail by Borges et al. (2003) . Briefly, mice were injected with methylscopolamine (1 mg/kg each i.p. in sterile 0.9 % NaCl, Sigma-Aldrich, St Louis, MO, USA) 30 min prior to administration of pilocarpine to minimize peripheral cholinergic effects. Experimental animals were then injected subcutaneously with a single dose of pilocarpine (330 mg/kg, in sterile 0.9 % NaCl, Sigma-Aldrich, St Louis, MO, USA). This dose of pilocarpine was chosen because it caused SE in only a fraction of CD1 mice (37 %) in a pilot study. Development of SE was visually observed for 90 min after pilocarpine injection and the onset and severity of behavioral manifestations were recorded. Seizures were scored according to the Racine scale (Racine 1972 ) with slight modifications (Borges et al. 2003) : normal activity (stage 0); rigid posture and/or immobility (stage 1); stiffened, extended, arched (Straub) tail (stage 2); unilateral forelimb clonus or head bobbing (stage 3); whole body continuous clonic seizures with retained posture (stage 3.5); bilateral forelimb clonus and rearing (stage 4); rearing and falling (stage 5); and tonic-clonic seizures with loss of postural control or jumping (stage 6). Stage 3.5-6 seizures were considered generalized (Shibley and Smith 2002) .
Status epilepticus was defined as at least 30 min of continuous seizure activity in which seizures were at least stage 3.5 in severity with one or more stage 5 or 6 seizures, or a minimum of three stage 4-6 seizures. After 90 min of behavioral SE, seizures were terminated by injection of 25 mg/kg pentobarbital (i.p.). Mice showing no behavioral seizure activity or \3 generalized seizures during 1.5 h of observation constituted the 'no SE' (NS) group and received an equal dose of pentobarbital 90 min after pilocarpine injection. After SE, all mice were injected with 0.5-1 ml 5 % glucose solution s.c. Mice were fed moistened high-fat rodent chow and monitored daily until they re-gained their preoperative body weight. Sham controls were 5 age-and weight-matched mice injected with equal doses of methylscopolamine and pentobarbital, but with an equivalent volume of saline instead of pilocarpine. Five mice served as naive controls.
Magnetic resonance imaging
After the termination of SE, 40 animals (17 SE, 13 NS mice, and 10 controls) were randomized into two groups for MR imaging at different time-points. Group I was imaged at 3 h and 7, 28, and 49 days and Group II was imaged at 1, 2, 14, and 35 days after pilocarpine injection. The length of the follow-up period was designed to cover the latent phase of epileptogenesis, lasting up to approximately 50 days in this model (Cavalheiro et al. 1996; Shibley and Smith 2002) .
Magnetic resonance imaging scans were acquired on a 16.4 Tesla 89 mm vertical bore scanner interfaced with an Avance II spectrometer (Bruker Biospin, Karlsruhe, Germany). Prior to scanning, mice were anesthetized with 4 % isoflurane in 2.0 L/min O 2 , and 1 ml of sterile 5 % glucose solution was injected subcutaneously to maintain the physical condition of the mice during scanning. Each mouse was placed in a prone position, in a custom made MRI compatible Micro2.5 Animal Handling System body and head restraint (M2M Imaging, Brisbane, Australia), to allow repeatable positioning and to minimize motion artifacts. Inside the scanner, anesthesia was maintained with 1.5-2.0 % isoflurane in O 2 at 1 L/min. Respiration was monitored with Biotrig (SpinSystems, Brisbane, Australia) and maintained at approximately 60-80 breaths per minute by adjusting the level of isoflurane and oxygen flow. A custom-built, 20 mm SAW volume head coil was used for both excitation and detection. The field-of-view (FOV) and the coronal position of the slices were adjusted to the axes of Paxinos mouse brain atlas (Paxinos and Franklin 2001) , which are similar to the axes used by the Australian Mouse Brain Consortium atlas.
Quantitative T2 MR images were acquired using a Multi-Slice-Multi-Echo sequence with TR = 2 s and the TE of 14, 28, 42, 56, 70, 84 ms, without respiratory gating. The imaging parameters were: FOV = 1.5 9 1.5 cm, matrix size 256 9 256 to produce a voxel size of 59 9 59 lm 9 1 mm thickness (9 contiguous coronal slices). The total acquisition time was 8.5 min.
2D coronal Stejskal-Tanner spin-echo diffusion-weighted images were acquired with respiratory gating using the sequence parameters: TR = 1.5 s, TE = 20 ms, and d/D = 2/12 ms. Multiple gradient strengths were applied in the slice direction to produce b values of 0, 400, 800, and 1,200 s/mm 2 . The same image slice, position and FOV was applied as the T2-map, with matrix size 128 9 128 to produce a voxel size of 117 9 117 lm 9 1 mm thickness (9 contiguous coronal slices). The total acquisition time was 17 min.
Image analysis T2 relaxation times were calculated by linear fitting of image intensity at different echo times using the formula ln(S) = ln(S 0 ) -t/T2 in which S is the image intensity, S 0 is the initial intensity, and t is the echo time. The apparent diffusion coefficient (ADC) at each voxel was calculated using the formula ln(S) = ln(S 0 ) -b 9 ADC.
Image preprocessing was performed with MIPAV4.4.1 (NIH, Bethesda, USA). The T2 images with echo time of 14 ms for each animal were used as the anatomic images for each mouse. Other images, including the T2 images with different echo times and DWI data, were registered to the corresponding anatomic images using rigid body registration based on normalized mutual information (NMI). A knowledge-guided active contour method was used to segment out the brain on anatomic images: (1) an averaged anatomic image was generated using two-pass rigid body and affine registrations to the anatomic images of the control animals; (2) the initial brain contour was manually defined on the averaged anatomic images; (3) the brain contour was transferred to the individual mouse images using the matrix found by rigid body registration of the averaged anatomic images to individual anatomic images; (4) the brain contour was actively adjusted to locate the individual brain contour using an energy minimizing B-spline method (Shan et al. 2005) . The brain masks found on anatomic images were applied to the T2 and ADC maps. Individual T2 and ADC brain maps were then normalized to the Australian Mouse Brain Mapping Consortium (AMBMC) brain template (Ullmann et al. 2012 ) using the transformation matrix found by a nonlinear cubic B-spline registration of individual anatomic brain images to the brain template using NMI.
Statistical parametric mapping with SPM8 (Wellcome Trust Centre for Neuroimaging, UK) was used to compare ADC and T2 maps between three different groups: control animals (CN), pilocarpine-treated animals with SE (SE), and pilocarpine-treated animals with no SE (NS). The analyses were performed on registered images smoothed with a 1 mm FWHM Gaussian kernel. Voxel-based unpaired t tests were used for group comparisons to identify the locations of significant differences in T2 and ADC at each time-point. The relative T2 and ADC changes at each voxel in the SE mice were also correlated with spike frequency in the randomly selected 96 h interval. Relative ADC values were calculated using:
in which ADC i;SE and ADC i;CN are the ADC value of the ith voxel in an individual subject in the SE group and the mean ADC value in the ith voxel in the control group, respectively. The relative T2 map was calculated similarly. The relative ADC/T2 changes were correlated with spike frequency using SPM8 (Wellcome Department of Cognitive Neurology, London, UK; http://www.fil.ion.ucl. ac.uk/spm/software/spm8/). The General Linear Model implemented in SPM8 was used with spike frequency as the covariate. For these analyses, a threshold following correction for multiple comparisons was selected for false discovery rate \0.05 (Genovese et al. 2002) . The voxels identified as strongly correlating with spike frequency in SPM8 were extracted from the ADC images. The mean value of relative ADC changes was calculated for each animal from those voxels. The Shapiro-Wilk test and Q-Q plots were used to test the normality of the relative ADC changes and the spike frequency. Linear regression was performed between these two parameters using SPSS for Windows (v.19.0, IBM, New York) . A receiver-operating characteristic (ROC) Curve for the ability of ADC values to predict spike frequencies dichotomized into those below the median and median and greater values was generated using a web-based implementation of JROCFIT (Eng 2006) .
Relative hippocampal volumes
Since hippocampal sclerosis (HS) is the most frequent lesion found in TLE, we also performed region of interest (ROI)-based analysis focusing on the hippocampus using MIPAV4.4.1 (NIH, Bethesda, USA). All slices containing the hippocampus (bregma levels 2.80 and -4.36 mm) on MR images for each mouse at each time-point were employed in this analysis. A blinded investigator manually delineated the left and right hippocampi and the whole brain on the anatomic images in native space. The relative hippocampal volumes were calculated as the ratio of the hippocampal volumes to the brain volumes in the respective slices. Statistical analyses were performed with SPSS (v.19.0) and the threshold for statistical significance was set at p \ 0.05. Kruskal-Wallis ANOVA was used to test for significance. If significant group differences were found on ANOVA, the Mann-Whitney U test was performed as a post hoc test to assess differences between two specific groups.
Electrode implantation
To detect and quantify SRS and to correlate epileptogenicity with MRI changes, we performed continuous video-EEG monitoring on 30 pilocarpine-injected animals and 4 controls for 3 consecutive weeks. Five to seven weeks after the induction of SE, the animals were anesthetized with a single i.p. injection (60 mg/kg) of sodium pentobarbital. The head of the mouse was secured in a stereotaxic apparatus (lambda and bregma on the same horizontal level) and the skull periosteum exposed by a midline skin incision. Two stainless steel epidural screw electrodes (1 mm diameter, Microbiotech/SE AB, Sweden) were placed over the left and right parietal cortex. Two additional screw electrodes were inserted into the skull over the cerebellum bilaterally and served as ground and indifferent electrodes. All electrode pins were inserted into the plastic pedestal (Plastics One Inc., Roanoke, VA, USA) and the entire assembly was cemented to the calvarium with dental acrylic (Vertex Castapress, Vertex-Dental B.V., Zeist, Netherlands). Five days after surgical procedures, the EEG was recorded in freely moving mice 24 h/day for three consecutive weeks, starting at 10-11 weeks after SE to detect SRS. Continuous video-EEG monitoring was performed using a Compumedics 32 Channel E-Series ProFusion EEG recording system with digital video, connected to an E-series 32 channel amplifier (Compumedics Ltd, Abbotsford, Victoria, Australia), using a sampling rate of 256 Hz. EEG recordings were filtered with a filter with 0.3 Hz high-pass and 100 Hz low-pass cut-offs. Mice were placed in plexiglass cages (30 9 18 9 21 cm) where they could move freely (one mouse per cage) and connected to the EEG recording system with commutators (Plastics One Inc., VA, USA). The behavior of the animals was recorded using 2 CCD video cameras (Panasonic SD5-S76250) positioned in front of the cages. The system allowed simultaneous video-EEG recording of 16 animals at a time.
Analysis of video-EEG
Digital EEG files were analyzed manually using proprietary ProFusion EEG software. An electrographic seizure was defined as a high amplitude rhythmic discharge or spike and wave pattern with a clear onset, offset, and temporal evolution in frequency and/or morphology, lasting at least 10 s. Behavioral severity of seizures was assessed on video according to the modified Racine scale (Racine 1972) . A spike was defined as a paroxysmal potential with sharp contour and a duration of 20-70 ms, usually followed by a low-voltage slow potential (about 200 ms duration). The number of spikes was counted manually from a 96 h period beginning at a randomly chosen starting point in the EEG recording.
Histology
Mice were deeply anesthetized using an intraperitoneal injection of 100 ll of Virbac Ò Lethabarb (325 mg/ml sodium pentobarbitone, Peakhurst, NSW, Australia). The animals were then transcardially perfused through the left ventricle and ascending aorta with ice-cold phosphate buffered saline (PBS, 0.01 M, pH 7.4) followed by ice-cold 4 % paraformaldehyde (PFA) in 0.01 M PBS. After postfixation in 4 % PFA for 24 h, the brains were stored at 4°C in 19PBS with 0.05 % sodium azide until being sectioned in coronal plane using a vibratome (VT 1000S, Leica Microsystems GmbH, Wetzlar, Germany, 40 lm thickness 1-in-12 series).
Immunohistochemistry
In the early post-injury phase, serial sections were analyzed from representative mice 48 h (n = 3) and 7 days (n = 3) after the injection of pilocarpine and SE lasting at least 1 h. The time-points were chosen as corresponding to the times of critical MRI changes. In the chronic post-injury phase, serial sections were analyzed from mice with electrographically confirmed epilepsy (n = 8), mice without epilepsy (n = 8), and untreated controls (n = 5). Free-floating sections were washed for 15 min in 0.01 M PBS (pH 7.4) followed by a 15 min wash in 50 % ethanol. The sections were then pre-treated in 19 PBST (0.15 % Triton X-100 in 19 PBS, pH 7.4) for 15 min. Non-specific staining was minimized by incubating sections in 10 % donkey serum (DS) in 19 PBST (pH 7.4) for 2 h. Sections were then incubated in a solution containing rat monoclonal antibody against mouse native C3 and its activation products, C3b, iC3b, C3d and C3dg (dilution: 1:100, Hycult Biotech, Uden, The Netherlands) for 48 h at 4°C. For doublelabeling of C3 with markers for astrocytes, neurons or microglia the sections were incubated with the following primary antibodies: mouse polyclonal antibody against glial fibrillary acidic protein (GFAP, dilution: 1:1,000, Millipore, Billerica, MA, USA), mouse monoclonal antibody against neuronal nuclei (NeuN, dilution 1:1,000, Millipore), or rabbit polyclonal antibody against ionized calcium binding adapter molecule 1 (Iba1, dilution: 1:1,000, Wako Pure Chemical Industries, Ltd, Osaka, Japan) for 2 h at room temperature with gentle agitation. The primary antibodies were diluted in 19 PBST and 2 % DS.
After washes with 19 PBST, sections were incubated for 2 h at room temperature in either Alexa Fluor 488 Goat Anti-Mouse IgG (dilution: 1:1,000, Life Technologies Corp, Grand Island, NY, USA) or Alexa Fluor 488 Goat Anti-Rabbit IgG (dilution: 1:1,000, Life Technologies Corp) diluted in 19 PBST to visualize astrocytes, neurons or microglia. After being washed, sections were then incubated for 2 h at room temperature in Alexa Fluor 594 Donkey Anti-Rat IgG (dilution: 1:1,000, Life Technologies Corp.) to visualize complement C3. The nuclei were counterstained with DAPI (dilution: 1:1,000, Life Technologies Corp.). Sections were then mounted on charged glass slides (superfrost plus) and coverslipped with Mowiol-488 for further analysis. Sections were examined using a light microscope (Axio Imager 2, Carl Zeiss Microscopy GmbH, Jena, Germany) with an ApoTome attachment (Axio Imager z1 stand). Fluorescence images were captured using a monochrome CCD camera (AxioCam HRm, Zeiss). The ApoTome structured-illumination attachment allowed optical sectioning using the CCD camera. The AxioVision software allowed automatic collection of multi-channel Z-stack images. Images were acquired with 59 and 209 lenses.
To quantitate differences in fluorescence, the data sets were processed using Imaris 7.6.1 software (Bitplane AG, Zurich, Switzerland). The 'Generate Surface' function was used to define the hilus of the hippocampus. The 'Surpass Scene' adaptive contour tracing tool was used to outline the hilus based on DAPI fluorescence signal. The area of the hilus (lm 2 ) was then measured using a built-in function. The hilar region of interest was then applied using red fluorescence as the channel of interest and the area within the hilus occupied by cells expressing C3 (lm 2 ) was determined by removing background and tissue fluorescence using absolute intensity threshold. The remaining total surface area was measured as representing cellular C3 labeling. For each animal the area with C3 fluorescence was calculated as a percentage of the hilar area. The correlation between the amount of C3 fluorescence calculated in this manner and spike frequency in a randomly selected 96 h interval on EEG was determined using Pearson correlation coefficient with SPSS19.
Results
Status epilepticus (SE)
Data are expressed as mean ± standard deviation. Behavioral manifestations included immobility followed by body tremor with a latency of 8 ± 3 min, that later developed in the following stages: mouth and facial automatisms, head nodding, unilateral forelimb clonus, bilateral forelimb clonus with rearing, rearing and falling/ loss of postural control. Mean latency to first seizure was 23.5 ± 3.4 min. Forty-two percent of injected mice (28 out of 67) experienced and survived behavioral status epilepticus (SE) as defined by continuous behavioral seizure activity consisting of mainly generalized clonic seizures and lasting at least 0.5 h. Stage 3-5 seizures were typically of 30-90 s duration and were separated by periods of continuous stage 1 and 2 seizure activity. The rest of the mice did not show any behavioral manifestations above score 1 or had 1-2 isolated seizures (score 2-3) during the 90 min observation period. Control animals receiving methylscopolamine and saline did not exhibit any behavioral alterations. The acute mortality rate for the pilocarpine-treated mice was 21 %, within the reported range (Shibley and Smith 2002; Borges et al. 2003) .
MR imaging
MR diffusion and relaxation changes in limbic regions reflect different outcome
The numerical values and anatomical locations of significant differences in ADC and T2 between the three groups are summarized in Tables 1 and 2 , and Figs. 1 and 2, respectively. In the NS group (NS vs. CN), MRI changes were confined to the hippocampus and amygdala between the first 24 h and 7 days most likely reflecting pilocarpine-induced and maximum T value of 5.61. The T value represents the ratio of intensity differences between two groups to the standard deviation of two groups; negative T value means the intensity in the first group is smaller than in the second group. If there are several clusters within a structure, the sum of the cluster volumes is reported.
''-'', no group difference detected by SPM * Short-term changes in the thalamus included ADC drop 1 day post-SE-SPM{t} 5.98 (-8.32), followed by increase 2 days post-SE-SPM{t} 5.22 (5.78), see Fig. 1b effects, as none of these animals had SE or observed SRS. This early increase in ADC and T2 returned to normal by 2 weeks (Figs. 1a, 2a ). This group did not exhibit MRI changes at later stages. In the SE group (SE vs. CN), in addition to the early hippocampal and amygdalar changes also observed in the NS group, later persistent MRI changes were observed in the parahippocampal and piriform cortices (Figs. 1b, 2b ). Given that they were not present in the NS group, these MRI changes are likely to contain a component that is SE-induced. The changes persisted throughout 7 weeks of MRI follow-up. Since all animals in the SE group had experienced SE and developed SRS (see below: Spontaneous recurrent seizures and interictal epileptiform activity), it was not possible to distinguish the changes caused by SE from those specifically related to epileptogenesis. The comparison of SE versus NS (i.e., epilepsy vs. no epilepsy) groups, revealed, however, a pattern of spatio-temporal MRI alterations different from that in SE versus CN comparison, with more widespread and severe damage to the amygdala and piriform cortex and more localized changes in the hippocampus and parahippocampal cortex in the group with epilepsy compared to non-epileptic animals (Tables 1, 2; Figs. 1c, 2c).
Dynamics of ADC changes in relation to epileptogenesis
Three to twenty-four hours post-SE, there was no difference in ADC maps between SE and NS groups. This may be an effect of residual exposure to pilocarpine which has direct neurotoxic and inflammatory effects. Animals in both groups received equal doses of pilocarpine which remains present in blood and brain up to 24 h after injection (Mazzuferi et al. 2012) . Forty-eight hours post-SE, an increase in ADC in the piriform, ectorhinal, perirhinal, and entorhinal cortices, amygdala, ventromedial thalamic nuclei, and the hippocampus was observed in SE animals ( Fig. 1c ; Table 1 ). A significant difference in ADC between SE and NS animals was present in the amygdala, piriform, and parahippocampal cortices for 2 weeks and subsided by 4 weeks ( Fig. 1c ; Table 1 ). In contrast, in the hippocampus, the difference between SE and NS groups in ADC persisted throughout the 7-week imaging period, in keeping with ongoing pathological changes in the hippocampus in SE animals destined to develop epilepsy ( Fig. 1c ; Table 1 ).
Dynamics of T2 changes in relation to epileptogenesis
Three to twenty-four hours post-SE, there was no difference in T2 maps between SE and NS groups. At 48 h, T2 increased in the amygdala in SE compared to NS animals ( Fig. 2c ; Table 2 ) and remained elevated throughout the 7-week period of observation. In the NS group, no T2 and maximum T value of 5.19. The T value represents the ratio of intensity differences between two groups to the standard deviation of two groups; negative T value means the intensity in first group is smaller than in the second groups. If there are several clusters within a structure, the sum of the cluster volumes is reported ''-'', no group difference detected by SPM Brain Struct Funct (2014) 219:683-706 689 changes in the amygdala were observed at any time-point except 48 h post-SE ( Fig. 2a ; Table 2 ). At 48 h post-SE, T2 increased in the hippocampus in both SE and NS animals when compared to controls ( Fig. 2a, b ; Table 2 ). The difference in hippocampal T2 between SE and NS groups appeared later, at day 7. By days 14-35, T2 changes had spread to involve the parahippocampal cortex ( Fig. 2c ; Table 2 ). Overall, differences in the hippocampus between the two groups were less prominent on T2 maps than on ADC maps.
Seven to fourteen days post-SE, in addition to changes in the amygdala and hippocampus, SE animals showed increased T2 values in the piriform cortex compared to NS group ( Fig. 2c; Table 2 ). T2 remained elevated to the end of the monitoring period, indicating that T2 may be more sensitive than ADC to damage in the piriform cortex and amygdala ( Fig. 2c; Table 2 ).
The absolute values of MRI changes in the limbic regions of all three groups are presented in Fig. 3 .
Hippocampal volume analysis
A consistent decrease in relative hippocampal volume was observed in the SE group compared to NS and control (CN) groups. This decrease started 24 h after the induction of SE and became significant at 7 days (Fig. 4) . No significant difference was found in relative hippocampal volumes between NS and CN groups.
SRS and interictal epileptiform activity
Occurrence of SRS
Monitoring was performed in 14 animals with SE, 16 mice with no SE (NS group) and 4 controls for 21 consecutive Fig. 1 Progression of ADC changes during epileptogenesis and epileptic maturation in a mouse pilocarpine TLE model. Voxel-based comparison of ADC maps generated for three groups of animals: controls (n = 10), mice that experienced status epilepticus after pilocarpine injection (SE group, n = 17), and mice without SE (NS group, n = 13). Data are presented in chronological order from 3 h to 49 days after the initial insult. Only the slices showing group differences at any one time-point are shown. a Sequence of ADC changes in NS group compared to control animals. b Spatio-temporal evolution of differences in ADC between SE and control groups. c Sequence of ADC changes in SE group compared to NS animals. The color scale bars on the left represent the T value, which can be negative (color-coded from blue to yellow) or positive (color-coded from green to red). The T values were calculated as ratios of differences between the two groups to the standard deviation of the two groups days. The NS group included 6 mice that had 1-2 isolated seizures after pilocarpine injection and 10 mice with no behavioral seizures after pilocarpine injection. None of the animals that failed to develop SE after pilocarpine injection exhibited any epileptiform changes on EEG during the entire period of monitoring. Video-EEG confirmed the presence of behavioral and electrographic SRS in 11 of the 14 SE mice (79 %). In the remaining three SE animals (21 %), continuous interictal spiking was recorded on EEG but no SRS were captured.
Characteristics of spontaneous chronic seizures
In mice with SRS, the mean seizure frequency was 0.5 ± 0.3 seizures per day (range 0.24-0.95 seizures per day) and the mean seizure duration was 51 ± 4.5 s (range 43.4-56.9 s). In all animals with SRS, electrographic seizures occurred with behavioral manifestations and were secondarily generalized (behavioral stage 4-5) according to the Racine scale (Racine 1972) . In seven mice, seizures appeared in clusters (up to 4 seizures within a 2 h recording period). Each animal also showed interictal spiking. Mean spike frequency in the 96 h spike-counting period was 13.1 ± 11.5 spikes per hour (range 1.05-39.9 spikes/h). There was a correlation between the number of spikes in a 96 h interval and the number of seizures within the 3-week monitoring period (r = 0.7; p \ 0.05). The three SE animals in which SRS were not recorded (an#20, an#37, an#66) had the lowest spike frequency (mean of 1.76 ± 0.25 spikes/h compared to 17.4 ± 11.5 spikes/h in those with observed SRS). Since animals without SE in our study did not show any epileptiform abnormalities on EEG, and animals with lower spike frequency did not exhibit SRS within 3 weeks of monitoring, it is reasonable to conclude that the presence and frequency of spiking activity reflected the severity of ongoing epileptogenesis. Fig. 2 Progression of T2 changes during epileptogenesis and epileptic maturation in a mouse pilocarpine TLE model. Voxel-based comparison of T2 maps generated for three groups of animals: controls, mice that experienced status epilepticus (SE) after pilocarpine injection (SE group) and mice without SE (NS group). Data are presented in chronological order from 3 h to 49 days after the initial insult. Only the slices showing group differences at any one timepoint are shown. a Sequence of T2 changes in NS group compared to control animals. b Spatio-temporal evolution of differences in T2 between SE and control groups. c Sequence of T2 changes in SE group compared to NS animals. Scale: the significance level of T values (ratios of differences between the two groups to the standard deviation of the two groups) were color-coded and overlaid onto the mouse template. The positive T values indicate that the intensities in the first group are greater than in second group and color-coded from green to red Quantitative MRI changes correlate with epileptogenicity
Epileptogenicity was defined as the presence and severity of epileptic condition (Engel 2011) . In light of the strong correlation between number of spikes and number of seizures, we used the number of interictal spikes as a quantitative descriptor of the intensity of the epileptogenic process. Spike frequency in a randomly selected 96 h interval was correlated with relative T2 and ADC changes (Fig. 5 ). For the ROI-based analysis, the distribution of both spike frequency and ADC values did not deviate significantly from normality (Shapiro-Wilk test; p = 0.08 and 0.07, respectively). Regression analysis showed that increased ADC values in the ventral hippocampus (at the level of bregma -3.4 mm) 7 days after SE correlated with spike frequency at the chronic stage (Fig. 5 ). The linear relationship between the spike frequency and ADC was strong (adjusted R 2 = 0.91; F 1,5 = 62.87, p = 0.001). The fitted binormal ROC curve is shown in Online Resource 1. The area under the fitted curve was 0.93 (±0.1 estimated standard error) indicating high predictive accuracy of ADC values. T2 changes or relative hippocampal volumes at any time point did not correlate with spike frequency. Figure 6 shows the pattern of C3 immunoreactivity in the hilar regions 48 h post-SE. Co-localization studies indicated that C3 was induced in reactive astrocytes, but not neurons or microglia, even though prominent microglial activation was present in all three animals. Double label immunostaining 1 week (Fig. 7 ) and 4 months (Fig. 8) post-SE showed a similar pattern of C3 immunoreactivity despite the presence of activated microglia. The hippocampus from CN animals showed weak C3 immunoreactivity in the hilar region and staining of blood vessels. One-week post-SE, when ADC increase in the ventral hippocampal region correlated with spike frequency, prominent reactive gliosis was found in the SE group with reactive astrocytes showing double labeling with C3 ( Fig. 9b-d) . In NS animals, there was less pronounced gliosis in the hippocampus than in SE mice and C3 expression was restricted to blood vessels (Fig. 9e, f) . Fig. 4 Evaluation of the time course of the hippocampal volume change on MRI following pilocarpine-induced status epilepticus. Data are presented for the three groups: mice that experienced status epilepticus (n = 17), mice without SE (n = 13), and controls (n = 10). Relative hippocampal volumes are shown as a ratio of the hippocampal volume to whole brain volume at each time-point. Graph illustrates the spread of data (from lowest to highest), the median, the mean (?), lower and upper quartiles. Note that there was a constant decrease in relative hippocampal volumes in the SE group, suggesting progression of damage. *p \ 0.05, **p \ 0.01 between the SE and NS groups. Fig. 3 Temporal changes in diffusion and T2 parameters in the limbic regions. Data are presented as mean ± SD from control animals (white bar), mice that did not experience status epilepticus (NS group, light gray bar) and those with status epilepticus and epilepsy (black bar). The absolute values are derived from the regions that showed significant difference voxel-wise within respective limbic structures. Asterisks mark statistically significant differences (p \ 0.05 with family wise error rate adjustment for multiple comparison implemented in SPM8) comparing data from SE mice to data from NS mice for each of the time-points. AMG amygdala, HC hippocampus, PIR piriform cortex, PHC parahippocampal cortex b Brain Struct Funct (2014) 219:683-706 695 Figure 10 illustrates the pattern of C3 immunoreactivity in the septal hippocampus in animals from each of the three groups 4 months post-SE. C3 was chronically upregulated in the hippocampus corresponding to the areas of significant MRI changes at 49 days post-SE (Fig. 10a) . In the CN hippocampus (n = 5), C3 immunoreactivity was barely detectable (Fig. 10b) . The pattern of C3 expression in NS animals (n = 10) was similar to controls ( Fig. 10c1-c3 ). In SE animals (n = 14), C3 was highly expressed by astrocytes in the hippocampus, particularly in the subgranular zone of the dentate gyrus ( Fig. 10d1-d3 ). In the three SE mice with interictal spiking on EEG but no spontaneous seizures during the 3-week monitoring period, the pattern of C3 expression in the dentate gyrus was similar to mice with SRS. Two out of the three animals had more severe hippocampal damage, and the third had less severe damage compared to animals with SRS (Online Resource 2 and 3).
C3 activation correlates with epileptogenicity
Since the maximal concentration of astrocytes overexpressing C3 was observed in the hilus of the dentate gyrus in all our experimental animals, we quantified the amount of C3 fluorescence for each animal as a proportion of the hilar area occupied by C3 cellular labeling. The amount of C3 fluorescence was significantly higher in SE than in NS animals (p \ 0.001) (Fig. 11a) . C3 overexpression in SE animals correlated positively with spike frequency in a randomly selected 96 h interval on EEG (p \ 0.01; r = 0.83) (Fig. 11b) .
Discussion
In the present study, we examined in vivo spatio-temporal evolution of structural and inflammatory changes immediately following SE and through the evolution to occurrence of SRS in a mouse model of TLE. The study produced three major findings: (1) MRI changes were dynamic, reflecting different outcomes in relation to the development of epilepsy. (2) ADC changes in the hippocampus at 7 days post-SE correlated with the severity of the evolving epilepsy. (3) C3 activation was found in all stages of epileptogenesis within the areas with significant MRI changes and correlated with the severity of epileptic condition.
Qualitative assessment of T2 changes following lithiumpilocarpine SE in rodents has been reported previously (Roch et al. 2002a, b) . There are also several comprehensive reports describing the dynamics of quantitative multiparametric MRI changes (Choy et al. 2010a, b; Duffy et al. 2012) in the first 3 weeks of pilocarpine-induced SE. All of these studies, however, have been performed in rats. Fig. 5 Correlation of MRI changes with epileptogenicity. a The relative ADC changes were correlated voxel-wise with the EEG results using spike frequency as a regressor. Scale: the significance level of T values (ratios of differences between the two groups to the standard deviation of the two groups) were color-coded and overlaid onto the mouse template. b A representative 5 s fragment of EEG showing interictal spikes (arrows) in two out of three animals with epilepsy (traces highlighted in pink). No epileptiform changes were observed in NS (highlighted in blue) or control animals (white) during 3 weeks of video-EEG monitoring. Each animal is represented by two consecutive traces on EEG. c The regression analysis was used to assess the relationship between relative ADC changes and spike frequency. The relative ADC changes were calculated as the mean intensities of the clusters identified in SPM8 (shown in a)
To our knowledge, this study is the first to report the detailed longitudinal characterization of changes in the mouse brain during the first 7 weeks after SE. More importantly, it is the first to correlate quantitative MRI changes, the inflammatory response and electrographically measured SRS and epileptogenicity in a model of TLE. In contrast to previous ROI-based imaging studies, we used voxel-based statistical parametric mapping to locate structural changes in the entire cerebrum. Because it does not impose an a priori restriction on the anatomical structures to be interrogated, our whole brain voxel-based approach is more sensitive to highly localized changes within structures that may be averaged out in ROI-based approaches. ROI-based methods are also susceptible to intra-and inter-rater variability in the delineation of anatomical boundaries.
Different time-course of MRI changes in relation to epilepsy development Magnetic resonance imaging changes reflect contributions from a number of processes such as direct neurotoxic and inflammatory effects of systemic pilocarpine injection, structural damage secondary to SE and structural changes directly related to epileptogenesis and epilepsy maturation that differ at each time point. In the NS group, increases in ADC and T2 in the hippocampus and amygdala were observed at 48 h after pilocarpine injection and resolved by 2 weeks. MRI changes in this group reflect the combined effect of pilocarpine-induced changes and ensuing occasional brief partial seizure activity (limbic seizures). Cholinergic exposure per se may lead to vasogenic edema and metabolic and inflammatory changes causing a temporary increase in ADC and T2. Pilocarpine acts on endothelial muscarinic receptors, compromising the integrity of the blood-brain barrier (Marchi et al. 2007; Uva et al. 2008) . It also causes peripheral inflammation (Marchi et al. 2009 ) and entry of proinflammatory cytokines into the brain through circumventricular organs may result in inflammatory changes (Riazi et al. 2010; Wuerfel et al. 2010) . Severe peripheral inflammation also causes blood-brain barrier disruption allowing leakage of ions and serum proteins such as albumin (Seiffert et al. 2004; Ivens et al. 2007) , altering homeostasis of neural microenvironment and neural activity ). Binding of pilocarpine to neuronal muscarinic receptors can alter neural activity by activating cholinergic systems. In the NS group, the threshold for pilocarpine-induced seizures was higher than in the SE group. It is likely that in the NS group, neuronal metabolism normalized, inflammation resolved and the affected areas recovered with minimal residual brain damage following the elimination of chemoconvulsant. This would explain the return of MRI parameters to normal, the animals' propensity to seizures being unchanged and the absence of inflammatory changes and significant hippocampal atrophy on histologic evaluation in the chronic stage. In contrast, in the SE group ADC and T2 changes in limbic regions persisted throughout the monitoring period. MRI changes observed during the acute phase (3-48 h) are likely to reflect a more severe injury due to the effects of pilocarpine injection, the ensuing SE and the processes underlying epileptogenesis. The residual effects of acute SE and MRI changes related to epileptogenesis proper could not be distinguished because all animals in this group eventually developed epilepsy. This may explain why no correlation was found between MRI changes at this stage and future development of epilepsy. Progressive changes were observed on follow-up MRI and confirmed by Quantitative MRI predicts degree of epileptogenicity We identified increased ADC in the ventral hippocampus at 7 days post-SE as a potential biomarker for the severity of the evolving epileptic state. We used the frequency of interictal spikes as an index of the severity of the epileptic condition; spike frequency was strongly correlated with the number of SRS. A relationship between the frequency of interictal spikes and the frequency of seizures, secondary generalization and SE has also been observed in patients with TLE (Rosati et al. 2003; Clemens et al. 2005; Janszky et al. 2005; Krendl et al. 2008) . Interictal spikes may contribute to the development and maintenance of the epileptic state by driving activity-dependent signaling and gene expression (Rakhade et al. 2007) .
The correlation of MR changes with chronic spike frequency was found at 7 days post-SE, early in the latent period. The latent period in the pilocarpine model is highly variable and strain-dependent (Cavalheiro et al. 1996; Shibley and Smith 2002; Chen et al. 2005; Winawer et al. 2007; Mueller et al. 2009 ). The number of animals exhibiting SRS following SE is a function of time. In previous studies on CD1 mice, the latent period lasted between 4 and 54 days, with a mean of 19 ± 8.9 days (Shibley and Smith 2002; Curia et al. 2008 ). In our study, the exact duration of the latent period in individual mice is unknown since concurrent EEG and MRI examinations were unfeasible due to signal drop out and image distortion from the magnetic susceptibility effects of intracranial EEG electrodes and breach of calvarium at ultra high-field strength. However, our long-term video-EEG monitoring results indicate that the latent period may be even longer than 54 days in some animals. Three out of 14 SE animals did not show behavioral and/or electrographic seizure activity up to 3 months post-pilocarpine treatment. On the basis of these data it is reasonable to assume that at 7 days post-SE, the vast majority, if not all, of the experimental animals were still in the latent phase. We therefore postulate that the MRI changes observed at this latent phase reflect epileptic maturation, i.e. evolution in the clinical phenotype (Pitkanen 2010; Dudek and Staley 2011; Sloviter and Bumanglag 2012) .
To date, few other experimental studies have investigated the ability of quantitative MRI to predict the progression of the epilepsy phenotype. Early decrease in hippocampal diffusivity correlated with lowered pentylenetetrazole-induced seizure threshold in a model of posttraumatic epilepsy (Kharatishvili et al. 2007 ) but in this study spontaneous seizures were not observed. In the Fig. 9 Distribution of C3 and GFAP immunoreactivity in the ventral hippocampus 7 days after pilocarpine-induced status epilepticus corresponds to the areas of MRI changes. a Significantly increased ADC values in the ventral hippocampus of SE animals compared to NS mice. b GFAP immunostaining of a representative animal from SE group. c Higher magnification of the hippocampal area shown in b. d Immunostaining of C3 in the mouse hippocampal tissue in a representative animal from SE group. e, f GFAP and C3 immunostaining of the corresponding ventral hippocampal area in a representative animal from NS group. Note prominent increased expression of C3 in astrocytes in the hilus and granule cell layer of the dentate gyrus, as well as ablation of CA1 in SE animal. Scale bar in c-f 100 lm. H hilus, gcl granule cell layer, CA1 Cornu Ammonis 1 region of the hippocampus proper electrical stimulation SE model, early alterations in diffusivity and fractional anisotropy in the amygdala and piriform cortex were found only in the animals with visible/ behavioral spontaneous seizures (Parekh et al. 2010 ) but because EEG analysis was not performed, the authors were unable to exclude subclinical seizures in the 'non-seizure' group. Our study is the first to correlate MRI changes with spontaneous epileptiform activity reliably detected and quantified with long-term video-EEG monitoring.
Complement activation is linked to epilepsy outcome C3 plays a central role in complement activation because it is the point of convergence of classical, alternative and lectin pathways. Our findings suggest a key role for C3 activation in the initiation of epilepsy. C3 was overexpressed early in the latent period (48 h-7 days post-SE). Persistent and prominent C3 activation in the hippocampus was observed only in SE animals, which, on the basis of observations on others in the cohort, were destined to develop epilepsy. A similar pattern of complement activation occurred both in animals with spontaneous seizures and in those with only interictal spikes. Moreover, we demonstrated the presence of activated C3 in the areas where MRI changes correlated with the development of epilepsy. Our data expand on previous observations of a complex and sustained inflammatory reaction that contributes to epileptogenesis following brain injury (Vezzani and Granata 2005; Marchi et al. 2009 Marchi et al. , 2011 Vezzani et al. 2008b Vezzani et al. , 2011a . Activation of the complement system, an important component of the inflammatory response, leads to activation of microglia, secretion of proinflammatory cytokines, recruitment of macrophages, activation of phagocytosis and increased vascular permeability (Lucas et al. 2006 ). Complement activation is increasingly recognized as playing a key role in the development of TLE. Prominent activation of the classical complement pathway occurs in the hippocampus and entorhinal cortex following SE in animal models (Aronica et al. 2007) , and C3 deficient mutant mice are less prone to develop epilepsy and have less severe pathological changes following brain infection (Libbey et al. 2010) . Glial and neuronal expression of C3 are observed in regions with neuronal loss in hippocampi of patients with TLE (Aronica et al. 2007 ) and microarray studies detect C3 upregulation in the entorhinal cortex (Jamali et al. 2006) . A functional polymorphism in the promoter region of the C3 gene confers susceptibility to TLE following febrile seizures (Jamali et al. 2010) .
In our study, the degree of C3 overexpression in the hilus of epileptic animals correlated strongly with epilepsy severity suggesting that C3 overexpression is also important in epileptic maturation. Reactive astrocytes within the hippocampus were the main source of complement components with C3 overexpression being particularly striking in astrocytes located in the subgranular zone (SGZ), the site of astrogenesis (Steiner et al. 2004; Borges et al. 2006) as well as neurogenesis. Altered astrocyte function due to C3 overexpression could modulate the remodeling of neuronal circuits by altering the microenvironment of neural stem cells, affecting neurogenesis (de Lanerolle et al. 2010; Verkhratsky et al. 2012) . Electrophysiological changes in astrocytes may also affect neuronal signaling in the dentate gyrus, which controls input to CA1 and CA3 areas, modulating hyperexcitability (Lee et al. 2007; Verkhratsky et al. 2012) . C3 activation products also regulate cytokine synthesis by monocytes, and in turn, cytokines (such as IL-b) induce C3 expression in astrocytes (Barnum and Jones 1995; Alexander et al. 2008) . Cytokines are thought to play a role in the development and propagation of seizures in TLE (Vezzani et al. 2008a (Vezzani et al. , b, 2011c Ravizza et al. 2008; Li et al. 2011; Kan et al. 2012) . C3 activation may also increase vascular permeability, allowing entry into the brain of substances such as albumin that promote ictogenesis (de Lanerolle et al. 2010; Weissberg et al. 2011 ) and pharmacoresistance (Abbott et al. 2002) . Further studies of complement activation during both epileptogenesis and epileptic maturation are required to clearly delineate its roles in each phase of the development of epilepsy and to identify novel therapeutic strategies.
Methodological issues
In previous studies of the rat pilocarpine model, MRI changes and their regional occurrence depended on the severity of acute seizures (Fabene et al. 2003; Nehlig 2011) . In our study, it is possible that in the acute stage (3-24 h post-SE) inter-animal variability in the number and severity of seizures contributed to variability in the levels of cell loss and edema, affecting the MRI results which did not reveal any differences between SE and NS animals. We note that to shorten scan acquisition times, diffusion data were acquired with gradients applied in the slice direction only. Maximum sensitivity is to changes in diffusion in this direction and lowest sensitivity is orthogonal to this plane. It is possible that diffusion measurements with gradients in other directions may detect additional abnormalities. Most histologic analysis was undertaken at a chronic stage, 12-16 weeks post-SE, to allow electrographic quantification of the seizure phenotype. Only a small number of representative animals were killed at the two acute time-points in which significant MRI changes were detected. Future studies at other time points and with larger cohorts will provide information on temporal progression of C3 activation. Co-registration of MRI with histology will also allow MRI changes to be directly correlated with underlying pathological changes. Fig. 10 Distribution of C3 immunoreactivity in the dorsal hippocampus 4 months after pilocarpine-induced status epilepticus. a Areas of significant ADC changes between SE and NS groups at 49 days poststatus epilepticus. b Immunostaining of C3 in the hippocampal tissue in a control animal. Control hippocampus shows weak C3 immunoreactivity in the hilar region and staining of blood vessels. c1-3 Immunostaining of C3 in the hippocampal tissue from three representative animals without epilepsy (NS group). d1-3 Immunostaining of C3 in the hippocampal tissue from three representative animals with spontaneous recurrent seizures (SE group). In non-epileptic animals weak C3 expression was found in the astrocytic processes in the hilus and molecular layers of the dentate gyrus and around lumina of blood vessels. In animals with epilepsy prominent increased expression was observed in cells with typical morphology of reactive astrocytes in the subgranular zone and in the inner, middle and outer molecular layers of the dentate gyrus. Scale bar 100 lm. CN control animal, NS animal without epilepsy, SE animal with epilepsy, H hilus, i inner molecular layer, m middle molecular layer, o outer molecular layer, gcl granule cell layer
Conclusion
In conclusion, this longitudinal study in a TLE mouse model is the first to relate the early ADC changes and chronic C3 activation with long-term epilepsy outcome. Early MRI changes may help to predict the likely course of developing epilepsy and thereby contribute to the development of diagnostic and disease-modifying strategies. The strong link between C3 expression and epilepsy severity found in this study encourages further research to establish whether treatment with specific complement antagonists can alleviate the symptoms of seizures or favorably alter the course of epilepsy. 
